Clinical trial Recruiting at 1 site Interventional Ages 18 to 50 Women only

Improving prenatal genetic testing decisions for better outcomes

Official title: Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes

Run by The Cleveland Clinic · NCT06382636 · Data updated 2026-11-12

This study is testing a new AI tool to help pregnant patients and their partners make better decisions about genetic testing during their pregnancy.

Quick facts

Study typeInterventional
Ages18 Years to 50 Years
SexWomen only
Enrollment600 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations3 sites (Cleveland, Ohio and 2 other locations)
StatusRecruiting
StartedMay 6, 2024
Main results expectedFebruary 28, 2027
Study endsFebruary 28, 2027
Registry record updatedAugust 3, 2026
Trial IDNCT06382636 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant individuals who are offered routine aneuploidy screening and diagnostic testing and can read and speak English.

Probably not a fit

Patients who are under 18 years of age, not currently pregnant, or unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the decision-making process for pregnant patients regarding Prenatal Screening and Diagnostic Testing (PS&D) by utilizing an innovative AI-powered engagement tool called OPUS. The trial will involve a randomized cluster design, focusing on the perspectives of patients, their partners, and healthcare providers. Through in-depth interviews and diverse participant recruitment, the study seeks to understand how social determinants and healthcare settings influence informed decision-making in prenatal care. The ultimate goal is to empower patients with the necessary resources to make informed choices about genetic testing.

Why it matters

Potential benefit: If successful, this study could lead to improved obstetric outcomes by enabling patients to make more informed decisions regarding prenatal genetic testing.

How similar studies have gone: Other studies have shown success with similar patient engagement approaches, indicating potential for positive outcomes in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Able to read and speak English
* Able to provide consent to participate in the study
* Offered routine aneuploidy screening and diagnostic testing

Exclusion Criteria:

* Less than 18 years of age
* Not currently pregnant or an intrauterine pregnancy has not yet been established
* Unable to provide informed consent for research participation
* Unable to read and speak English

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting
  • Neighborhood Family Practice
    Cleveland, Ohio, United States
    Not yet recruiting
  • MetroHealth Medical Center
    Cleveland, Ohio, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Ruth Farrell, MD, MA — The Cleveland Clinic
  • Study coordinator: Ruth Farrell, MD, MA
  • Email: farrelr@ccf.org
  • Phone: 216-445-7085

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.